|University of Michigan, Ann Arbor - Honors Program; BS
Stanford University School of Medicine; Stanford, CA; MD
Kaiser Permanente; Santa Clara, CA: Internal Medicine Internship
Harvard-Longwood Neurology Residency Training Program
Clinical Neurophysiology Fellowship at Cedars-Sinai Medical Center/UCLA
09/1984 - 05/1988
06/1988 - 06/1992
06/1992 - 06/1993
07/1993 - 06/1996
07/1996 - 06/1997
|American Board of Psychiatry and Neurology (ABPN)
ABPN Subspecialty Certification in Clinical Neurophysiology
|President/CEO – Tower Neurological Services, Medical Corp.
Director of Neuromuscular Services, Cedars-Sinai Medical Center
Assistant Director, Neurophysiology Laboratory at Cedars-Sinai Medical Center
Associate Clinical Professor of Medicine, UCLA
Co-Director of the MDA-affiliated Neuromuscular Center at Cedars-Sinai Medical Center
Sub-Investigator for the ATLANTIS Stroke Trial
Principal Investigator for Citicoline Stroke trial
Principal Investigator for Topiramate in Diabetic Peripheral Neuropathy Trial
Member of the American Academy of Neurology since
Member of the American Association of Electrodiagnostic Medicine
Member of the American Medical Association
Director of the Neurology Training Program at Cedars-Sinai Medical Center
Voting member of General Clinical Research Center Scientific Advisory Committee
04/2004 - 08/2004
07/2002 - 08/2004
07/1997 - 08/2004
07/2002 - 08/2004
02/2000 - 08/2004
12/1997 - 08/1998
04/1999 - 08/1999
04/2000 - 08/2004
05/1998 - 08/2004
10/1998 - 08/2004
12/1999 - 08/2004
04/2002 - 08/2004
04/1998 - 12/2001
HONORS AND SPECIAL AWARDS:
Honored Member of Strathmore’s Who’s Who
Named in Outstanding People of the 21st Century for contribution to Education
Special Award for Outstanding Achievement in Electromyography
Phi Beta Kappa
Outstanding Teaching Award in Neurology, UCLA
“Molecular Genetic Testing for Inherited Myopathies”, at American Academy of Neurology, 04/1998
“Selected Neuromuscular Diseases”, at UCLA Intercampus Medical Genetics Training Program, 05/1998, 05/1999
Medicine Boards Neurology Review, at Cedars-Sinai Medical Center, 1998-2001
“Assessment of Infant Neuromuscular Diseases”, Cedars-Sinai Medical Center, 11/24/1998
“Emergency Medicine Lecture Series – Neurology”, at Cedars-Sinai Medical Center, 08/30-31/1999, 08/1-02/2000
“Immunotherapy for Neuromuscular Diseases”, at Cedars-Sinai Medical Center, 12/27/1999
“Critical Illness Neuromyopathy” at Cedars-Sinai Medical Center, 06/21/00, 05/11/2001
EMG/NCS in Rheumatic Disease – Rheumatology Grand Rounds, 5/16/2001
Lecture on Neuropathy/IVIg given to the Neuropathy Association support group – 02/07/2001
“Advances in Genetics of Neuromuscular Disorders” Kaiser Permanente Annual Neurology
“Review of Modern EMG/Nerve Conduction Study Techniques in the Evaluation of Orthopedic, Neurosurgical and Neurological Patients” – 10/16/2001
“Advanced Diagnosis of Neuromuscular Disorders”, Kaiser Permanente, Bellflower, CA, 8/26/02
RESEARCH GRANTS & FELLOWSHIPS RECEIVED:
|NIH CAP Award (3 MO1 RR00425-2856);
“Analysis of a novel muscular dystrophy linked to keloids”;
Total direct costs: $364,256; 7/1/98 - 6/30/01; Principal Investigator
“Molecular Analysis of Muscular Dystrophies, Amyotrophic Lateral Sclerosis and Related Disorders”,
Total direct costs: $33,615; 12/1/98 - 11/30/99; Principal Investigator
RESEARCH PAPERS (PEER REVIEWED)
A. RESEARCH PAPERS - PEER REVIEWED
1. Hekmatpanah J, Hekmatpanah CR. Microvascular alterations following cerebral contusion in rats. J Neurosurg. 1985;62:888-897.
2. Hekmatpanah CR, McKenna DJ, Peroutka SJ: Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat. Neuroscience Letters. 1989; 104:178-182.
3. Hekmatpanah CR, Peroutka SJ. 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Eur J Pharm. 1990; 177:95-98.
4. Hekmatpanah J, Haghighat N, Adams CR. Alcohol consumption by nursing rats and its effect on the cerebellum of the offspring. Alcohol & Alcoholism. 1994; 29:535-547.
5. Adams C, Starkman S, Pulst SM. Clinical and molecular analysis of a pedigree of southern Italian ancestry with spinocerebellar ataxia type 2. Neurology. 1997;49:1163-1166.
6. Kuo A, Pulst S, Eliashiv D, Adams C. Electrical inexcitability of nerves and muscles in severe infantile spinal muscular atrophy. J Neurol, Neurosurg, Psych. 1999; 67(1):122.
7. Adams C, Eliashiv D. Preservation of the brainstem auditory evoked potential in non-convulsive status epilepticus. Clin Neurophysiol 2000;111(7):1330-2.
8. Adams C, Figueroa KP, Zu L, Anderson TL, Graves MC, Garcia CA, Pulst SM. Bethlem myopathy in a Black Creole Pedigree. J Clin Neuromusc Dis. 2002;4(1):7-10.
1. Peroutka SJ, Sleight AJ, McCarthy BG, Pierce PA, Schmidt AW, Hekmatpanah CR. The clinical utility of pharmacological agents that act at serotonin receptors. J Neuropsychiatry. 1989; 1:253-262.
2. Myotonic Dystrophy. Chapter in GeneClinics (www.geneclinics.com), 1999, an electronic medical database.
3. Padberg G and Adams C. Facioscapulohumeral Muscular Dystrophy. In Pulst SM (ed): Neurogenetics, 2000. Oxford University Press, New York.
4. Roses AD and Adams C. Myotonic Dystrophy. In Pulst SM (ed): Neurogenetics, 2000. Oxford University Press, New York.
1. Gottlieb LJ, Hekmatpanah CR, Krizek TJ, Melton C. Effect of vitamin A on skin allografts in rats immunosuppressed by cortisone. Surgical forum 1986;37:601-603.
2. Figueroa KP, Zu L, So Y, Adams C, Pulst SM. Evidence for a Second Locus for Rippling Muscle Disease (RMD). Neurology 1999;52:A122.
3. Adams C, Pulst SM. A New Pedigree of Creole Decent with Probable Bethlem Myopathy and Predisposition to Keloid Formation. Abstract for annual GCRC meeting, 2000.
4. Ghandi R, Eliashiv D, Adams C. Re-visiting normative data for femoral nerve conduction studies. Abstract in Muscle & Nerve, American Association of Electrodiagnostic Medicine, 2000.
5. Adams C, Guo M. Rigid spine syndrome associated with a demyelinating polyneuropathy. Journal of the Neurological Sciences 2001;187:S376.
6. Adams C, Elsas SM, Eliashiv D. Electrographic epileptiform features in patients with Creutzfeldt-Jakob disease. Journal of the Neurological Sciences 2001;187:S230.
7. Adams C, Pulst SM. Mixed neurogenic and myopathic electromyographic pattern in facioscapulohumeral muscular dystrophy, type 1A. Journal of the Neurological Sciences 2001;187:S513.
BACK TO TOP